Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin

International Journal of Infectious Diseases

Volumn 13, Issue 5, 2009, Pages

  Benenson, Shmuel ^a   Navon Venezia, Shiri ^b   Carmeli, Yehuda ^b   Adler, Amos ^a   Strahilevitz, Jacob ^a   Moses, Allon E ^a   Block, Colin ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

blaKPC3 gene; Carbapenem resistant Klebsiella pneumoniae; Colistin; Gentamicin; Infective endocarditis

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEPHALOSPORIN DERIVATIVE; COLISTIN; CREATININE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; TROPONIN;

ACUTE HEART INFARCTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATE; BLA KPC3 GENE; BLOOD CULTURE; BURN; CASE REPORT; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; DYSPNEA; FEVER; GENE; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; KLEBSIELLA PNEUMONIAE INFECTION; LEUKOCYTE COUNT; MALE; MITRAL VALVE; PLASTIC SURGERY; ST SEGMENT ELEVATION; THORAX PAIN; WOUND INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; COLISTIN; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; GENTAMICINS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; TREATMENT OUTCOME;

EID: 68949202385     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.01.006     Document Type: Article

References (18)

1. Bratu S., Landman D., Haag R., Recco R., Eramo A., Alam M., et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165 (2005) 1430-1435
2. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M.J., and Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51 (2007) 3026-3029
3. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational supplement (M100-S17). Wayne, PA: CLSI; 2007.
4. Navon-Venezia S., Chmelnitsky I., Leavitt A., Schwaber M.J., Schwartz D., and Carmeli Y. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 50 (2006) 3098-3101
5. Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., Schwartz D., Leavitt A., and Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52 (2008) 1028-1033
6. Tenover F.C., Kalsi R.K., Williams P.P., Carey R.B., Stocker S., Lonsway D., et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12 (2006) 1209-1213
7. Anderson K.F., Lonsway D.R., Rasheed J.K., Biddle J., Jensen B., McDougal L.K., et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 45 (2007) 2723-2725
8. Baskin T.W., Rosenthal A., and Pruitt B.A. Acute bacterial endocarditis: a silent source of sepsis in the burn patient. Ann Surg 184 (1976) 618-621
9. Trexler Hessen M., and Abrutyn E. Gram-negative bacterial endocarditis. In: Kaye D. (Ed). Infective endocarditis (1992), Raven Press, New York
10. Anderson M.J., and Janoff E.N. Klebsiella endocarditis: report of two cases and review. Clin Infect Dis 26 (1998) 468-474
11. Zimhony O., Chmelnitsky I., Bardenstein R., Goland S., Hammer Muntz O., Navon Venezia S., et al. Endocarditis caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility. Antimicrob Agents Chemother 50 (2006) 3179-3182
12. Baddour L.M., Wilson W.R., Bayer A.S., Fowler Jr. V.G., Bolger A.F., Levison M.E., et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111 (2005) e394-434
13. Mentec H., Vallois J.M., Bure A., Saleh-Mghir A., Jehl F., and Carbon C. Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. Antimicrob Agents Chemother 36 (1992) 1883-1889
14. Kobasa W.D., and Kaye D. Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits. Antimicrob Agents Chemother 24 (1983) 321-324
15. Rodriguez-Hernandez M.J., Jimenez-Mejias M.E., Pichardo C., Cuberos L., Garcia-Curiel A., and Pachon J. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis. Clin Microbiol Infect 10 (2004) 581-584
16. Dor V., Gioanni T., Mermet B., Diesnis P., Kreitmann P., Schmitt R., et al. [Pseudomonas endocarditis on aortic valve prosthesis. Successful treatment by association of tobramycin-rifampicin-colistin and two reinterventions. Follow-up of 5 years (author's transl)]. Ann Chir 35 (1981) 163-165
17. Tascini C., Ferranti S., Messina F., and Menichetti F. In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate. Clin Microbiol Infect 6 (2000) 690-691
18. Bratu S., Tolaney P., Karumudi U., Quale J., Mooty M., Nichani S., et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56 (2005) 128-132